Key details of the duodenal-jejunal bypass in type 2 diabetes mellitus rats
- PMID: 22174553
- PMCID: PMC3236578
- DOI: 10.3748/wjg.v17.i45.5021
Key details of the duodenal-jejunal bypass in type 2 diabetes mellitus rats
Abstract
Aim: To investigate which surgical techniques and perioperative regimens yielded the best survival rates for diabetic rats undergoing gastric bypass.
Methods: We performed Roux-en-Y gastric bypass with reserved gastric volume, a procedure in which gastrointestinal continuity was reestablished while excluding the entire duodenum and proximal jejunal loop. We observed the procedural success rate, long-term survival, and histopathological sequelae associated with a number of technical modifications. These included: use of anatomical markers to precisely identify Treitz's ligament; careful dissection along surgical planes; careful attention to the choice of regional transection sites; reconstruction using full-thickness anastomoses; use of a minimally invasive procedure with prohemostatic pretreatment and hemorrhage control; prevention of hypothermic damage; reduction in the length of the procedure; and accelerated surgical recovery using fast-track surgical modalities such as perioperative permissive underfeeding and goal-directed volume therapy.
Results: The series of modifications we adopted reduced operation time from 110.02 ± 12.34 min to 78.39 ± 7.26 min (P < 0.01), and the procedural success rate increased from 43.3% (13/30) to 90% (18/20) (P < 0.01), with a long-term survival of 83.3% (15/18) (P < 0.01).
Conclusion: Using a number of fast-track and damage control surgical techniques, we have successfully established a stable model of gastric bypass in diabetic rats.
Keywords: Damage control surgery; Duodenal-jejunal bypass; Fast-track surgery; Goal-directed volume therapy; Minimally invasive surgery; Permissive underfeeding; Type 2 diabetes mellitus.
Figures


Similar articles
-
Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats.Surg Obes Relat Dis. 2017 Feb;13(2):250-260. doi: 10.1016/j.soard.2016.08.500. Epub 2016 Aug 31. Surg Obes Relat Dis. 2017. PMID: 27865809
-
Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.Obes Surg. 2018 May;28(5):1313-1320. doi: 10.1007/s11695-017-2985-y. Obes Surg. 2018. PMID: 29098544
-
Establishing a successful rat model of duodenal- jejunal bypass: A detailed guide.Lab Anim. 2019 Aug;53(4):362-371. doi: 10.1177/0023677218797370. Epub 2018 Sep 18. Lab Anim. 2019. PMID: 30227760
-
Endoscopic Therapeutic Option for Weight Loss and Control of Type 2 Diabetes: the Duodenal-Jejunal Bypass Liner.Surg Technol Int. 2015 May;26:115-9. Surg Technol Int. 2015. PMID: 26054998 Review.
-
Bariatric surgery: effects on glucose homeostasis.Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):497-507. doi: 10.1097/01.mco.0000232914.14978.c5. Curr Opin Clin Nutr Metab Care. 2006. PMID: 16778583 Review.
References
-
- Campos GM, Rabl C, Peeva S, Ciovica R, Rao M, Schwarz JM, Havel P, Schambelan M, Mulligan K. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg. 2010;14:15–23. - PMC - PubMed
-
- Laferrère B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa B, Koshy N, Lee H, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93:2479–2485. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials